Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. - Wikidata - wikimedia - TriplyDB

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

http://www.wikidata.org/entity/Q33292289

about

Bag6 complex contains a minimal tail-anchor-targeting module and a mock BAG domain Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress Evasion from NK cell-mediated immune responses by HIV-1 Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies The role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetes HLA-dependent tumour development: a role for tumour associate macrophages?Coevolution of MHC genes (LMP/TAP/class Ia, NKT-class Ib, NKp30-B7H6): lessons from cold-blooded vertebrates Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin Elucidating the mechanisms of influenza virus recognition by Ncr1 Overexpression of peroxisomal testis-specific 1 protein induces germ cell apoptosis and leads to infertility in male mice Bat3 deficiency accelerates the degradation of Hsp70-2/HspA2 during spermatogenesis.BAT3 regulates Mycobacterium tuberculosis protein ESAT-6-mediated apoptosis of macrophages Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function Killing of avian and Swine influenza virus by natural killer cells Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway A novel BAT3 sequence generated by alternative RNA splicing of exon 11B displays cell type-specific expression and impacts on subcellular localization.Increase of IFN-γ and TNF-α production in CD107a + NK-92 cells co-cultured with cervical cancer cell lines pre-treated with the HO-1 inhibitor.Oncogenic stress sensed by the immune system: role of natural killer cell receptors Coordinated regulation of NK receptor expression in the maturing human immune system.Recognition of tumors by the innate immune system and natural killer cells.Evasion of natural killer cells by influenza virus.Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack The structural basis of ligand recognition by natural killer cell receptors.Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape.Natural killer cells: role in local tumor growth and metastasis A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen.Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.Human herpesviridae methods of natural killer cell evasion

P2860

Q24311324-501FF162-AC2F-4BF8-B478-AEE4FD976CDB Q24615889-2152234C-10A4-403F-9484-F9BE82BA2693 Q24651041-435E1F79-5B92-43CF-AAF2-B6FEA4929B97 Q26781260-4BECE4B2-3663-462D-88D1-1DAA4F9C9203 Q26864489-3AB052E9-11DC-4A24-B86A-B56B540B5FCF Q26996660-5CE45794-AB63-44AF-8587-514D7997E4BB Q27003384-51AB399B-D709-4538-87F4-6D243BA7863B Q27022124-00057139-A9BD-4E1E-B1D9-6246CF12B51B Q28081315-D8BB76BF-45F6-4223-89A0-88774F27BA06 Q28476707-94734621-F946-4AEC-B4FE-E9F9DCB9E1B0 Q28586365-15766EBB-4944-45F0-BFF4-26E87042D575 Q28587046-946C4BDF-84BA-4E31-9189-6D8F455D51E9 Q28592901-E4F13F7F-7D10-41EE-80A0-5E94C5C64ACE Q28727070-88E92321-113C-49EE-AADA-613E53D49087 Q28854563-82E59DAB-5E50-47FF-8C30-8B2A7C7877FA Q30385326-EFC97C78-3CB2-4CDB-962B-79825C87B8FB Q30668576-5A43E892-9E5F-412E-B366-32D17669EA41 Q30975364-B6651FA6-6902-4882-9EA7-05D66EB249F0 Q33292180-0A394790-A9B8-4415-A30F-D0BA8E5DAE8A Q33292224-250F1520-6C75-4BC4-B555-1EE63F110CD1 Q33292470-0B37C0C3-C0F4-490E-8D82-427A4289955C Q33292532-219A16CB-52B8-4D4B-8E19-577E171DA7AC Q33672480-F0ED0027-8639-4B8D-88E4-BD9085FCDB86 Q33914138-D8D59315-40A6-46F9-A18B-2EE5C4D05749 Q34256996-F44E20A0-0DA0-4B1D-A133-618922FD14D5 Q34308800-3B0058E0-D92F-4566-8F47-699ABE5E989C Q34473267-B5E3BCFC-AD21-4916-98F2-B5217C2A32A9 Q34476273-D0E7F012-48B7-4F76-A139-6F99E2C3F64B Q34496462-2F1FC8A8-2B48-4D5F-8790-2FAC914287C5 Q34510128-51737F39-4816-4254-903F-3DBC03613D51 Q34580297-EDA37D97-F411-4E71-97FE-0C5AE83C299B Q35001148-22DB8DF7-B48B-4560-9F3A-BC704497783C Q35083496-705A9A46-6E46-417D-BC16-6527E9A7F9BB Q35131244-3EB5D7F9-19C9-4F9C-92DD-C661791D5B69 Q35687743-B590F86F-C86D-47CE-BFA7-C02E8DEFB29B Q35798978-C3C0E230-6D90-405C-89AC-85E3160D153B Q35905953-BC2B8CC2-A26E-4A6F-9ACC-46B909A30988 Q36057472-34C4FC01-0FB4-4429-85CC-E87FAA2806AC Q36094697-DE765A32-DE30-40A9-9D44-C81616902849 Q36102137-ABC56E61-5630-4FAE-987B-3F064E07B4ED

P2860

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

http://www.wikidata.org/entity/Q33292289

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Human leukocyte antigen-B-asso ...... eptor on natural killer cells.

@ast

Human leukocyte antigen-B-asso ...... eptor on natural killer cells.

@en

type

label

Human leukocyte antigen-B-asso ...... eptor on natural killer cells.

@ast

Human leukocyte antigen-B-asso ...... eptor on natural killer cells.

@en

prefLabel

Human leukocyte antigen-B-asso ...... eptor on natural killer cells.

@ast

Human leukocyte antigen-B-asso ...... eptor on natural killer cells.

@en

P1433

Q33292289-4C5FB8DB-BEBB-4B60-A8C2-107537A21565

P1476

Q33292289-1588C891-2A87-4BF5-A5F8-FCF5B281ED0E

P2093

Q33292289-06DA4FAC-011D-4F40-BD21-8261BFD2BE76

Q33292289-1E262467-AE62-4DEE-B723-F4A97D467B23

Q33292289-3EFFA7CA-AC56-47B9-970E-EBA4EFF29EE1

Q33292289-4B018309-D7CA-4E4B-A6F7-5856DA53A52D

Q33292289-59F34519-4C00-4616-AAC0-BE71086DAB65

Q33292289-8D8630EC-98C9-4357-83E2-B27C92E2D10C

Q33292289-90A9C551-84D2-4AB1-ADD3-61F48A61BF41

Q33292289-9AB2F604-1BA9-449C-828C-9FB05D6AA9BE

Q33292289-BF9979E5-C185-4D81-8673-AEA56794E2D8

Q33292289-CB4F926D-47C3-4450-86F1-E7A4C01FBE28

P304

Q33292289-C573F10E-E0B7-4504-8538-91ABE0658687

P31

Q33292289-4E841C45-06C6-464F-A281-9F1FC66A4615

P356

Q33292289-CC9576BF-C6EB-4507-B969-2C537247E00E

P407

Q33292289-E678003E-1C1F-439C-A44A-BA2B77A7BCF0

P433

Q33292289-4EED2E65-0BB9-4656-8520-10F698076DA2

P478

Q33292289-A6779F0F-C954-4099-9A4A-37CBD40E36B0

P50

Q33292289-A1088571-D39E-4531-8FD4-F6CEA8B632DF

Q33292289-B8377ED6-BC9B-4BB6-A575-DF859AFAC5FB

P577

Q33292289-011C8AAF-BDEC-430E-BCDD-9BFEF24D2284

P698

Q33292289-C654BB9E-3D83-4893-AF5E-C2678E74AFFB

P356

J.IMMUNI.2007.10.010

P1433

P1476

Human leukocyte antigen-B-asso ...... eptor on natural killer cells.

@en

P2093

Achim Rothe

http://www.w3.org/2001/XMLSchema#string

Andreas Engert

http://www.w3.org/2001/XMLSchema#string

Bastian von Tresckow

http://www.w3.org/2001/XMLSchema#string

Boris Böll

http://www.w3.org/2001/XMLSchema#string

Hinrich P Hansen

http://www.w3.org/2001/XMLSchema#string

Katrin S Reiners

http://www.w3.org/2001/XMLSchema#string

Peter Borchmann

http://www.w3.org/2001/XMLSchema#string

Peter J McKinnon

http://www.w3.org/2001/XMLSchema#string

Stephanie Sasse

http://www.w3.org/2001/XMLSchema#string

Venkateswara Rao Simhadri

http://www.w3.org/2001/XMLSchema#string

P304

965-974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2007.10.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Elke Pogge von Strandmann

P577

2007-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18055229

http://www.w3.org/2001/XMLSchema#string